Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intercept Pharmaceuticals (ICPT)

Intercept Pharmaceuticals (ICPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Biotech Stock Roundup: GILD Prices Remdesivir, VXRT Rises, ICPT Plunges & More

The biotech sector remains in focus with updates on coronavirus treatments and other pipeline developments.

ALXN : 102.49 (-2.21%)
GILD : 69.53 (-3.87%)
VRTX : 272.00 (-2.65%)
ZGNX : 23.79 (-2.30%)
ICPT : 45.64 (-2.27%)
VXRT : 9.39 (-5.34%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or "the Company") (NASDAQ:...

ICPT : 45.64 (-2.27%)
Intercept Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASH

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced...

ICPT : 45.64 (-2.27%)
Watch for Intercept Pharma to Potentially Pullback After Gaining 2.25% Yesterday

Intercept Pharma (NASDAQ:ICPT) traded in a range yesterday that spanned from a low of $81.02 to a high of $83.57. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high...

ICPT : 45.64 (-2.27%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. - ICPT

Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT). Such investors are advised to contact Robert S. Willoughby...

ICPT : 45.64 (-2.27%)
7.3% Return Seen to Date on SmarTrend Intercept Pharma Call (ICPT)

SmarTrend identified a Downtrend for Intercept Pharma (NASDAQ:ICPT) on May 22nd, 2020 at $78.97. In approximately 3 weeks, Intercept Pharma has returned 7.31% as of today's recent price of $73.19.

ICPT : 45.64 (-2.27%)
Why Is Intercept (ICPT) Down 9.4% Since Last Earnings Report?

Intercept (ICPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ICPT : 45.64 (-2.27%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. - ICPT

Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT). Such investors are advised to contact Robert S. Willoughby...

ICPT : 45.64 (-2.27%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. - ICPT

Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT). Such investors are advised to contact Robert S. Willoughby...

ICPT : 45.64 (-2.27%)
Biotech Stock Roundup: REGN's Stake Buyback, INO, NVAX's Coronavirus Updates & More

The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.

REGN : 632.07 (+0.10%)
SNY : 52.45 (-0.10%)
NVAX : 143.10 (-2.40%)
INO : 19.44 (-6.22%)
ICPT : 45.64 (-2.27%)
ARGX : 230.13 (-1.83%)
Intercept Down on Postponement of AdCom Meet for NASH Drug

The FDA defers advisory committee meeting date pertaining to Intercept's (ICPT) NDA for obeticholic acid to treat liver fibrosis due to nonalcoholic steatohepatitis.

GILD : 69.53 (-3.87%)
ICPT : 45.64 (-2.27%)
AKCA : 10.84 (-6.47%)
GNFT : 4.91 (+2.51%)
Intercept Pharma Falls 14.52% on Heavy Volume: Watch For Potential Rebound

Intercept Pharma (NASDAQ:ICPT) traded in a range yesterday that spanned from a low of $76.31 to a high of $81.62. Yesterday, the shares fell 14.5%, which took the trading range below the 3-day low of...

ICPT : 45.64 (-2.27%)
Intercept Provides Regulatory Update

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced...

ICPT : 45.64 (-2.27%)
Intercept's (ICPT) Q1 Earnings and Revenues Beat Estimates

Intercept (ICPT) reports better-than-expected results for the first quarter of 2020 on solid Ocaliva sales.

GILD : 69.53 (-3.87%)
AGN : 193.02 (+0.02%)
ICPT : 45.64 (-2.27%)
GNFT : 4.91 (+2.51%)
Intercept Pharma Has Returned 35.3% Since SmarTrend Recommendation (ICPT)

SmarTrend identified an Uptrend for Intercept Pharma (NASDAQ:ICPT) on March 26th, 2020 at $66.98. In approximately 2 months, Intercept Pharma has returned 35.32% as of today's recent price of $90.63.

ICPT : 45.64 (-2.27%)
Intercept Pharmaceuticals (ICPT) Reports Q1 Loss, Tops Revenue Estimates

Intercept (ICPT) delivered earnings and revenue surprises of 2.72% and 6.42%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

ICPT : 45.64 (-2.27%)
Intercept: 1Q Earnings Snapshot

NEW YORK (AP) _ Intercept Pharmaceuticals Inc. (ICPT) on Monday reported a loss of $93 million in its first quarter.

ICPT : 45.64 (-2.27%)
Intercept Pharmaceuticals Reports First Quarter 2020 Financial Results, and Provides Business Update

Worldwide Ocaliva net sales of $72.7 million in the first quarter 2020, representing 40% growth over the prior year quarter

ICPT : 45.64 (-2.27%)
Intercept to Present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced...

ICPT : 45.64 (-2.27%)
Intercept to Announce First Quarter 2020 Financial Results on May 11, 2020

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce...

ICPT : 45.64 (-2.27%)

Van Meerten Stock Picks

Ebay - Pick of the Day
Today Ebay (EBAY) is a Volume Leader on Barchart: 100% technical buy signals Trend Spotter buy signal Above its 20, 50 and 100 Day moving averages 16 new highs and up 26.
EBAY +0.56
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar